The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
Delhi win shatters myth that PM’s appeal confined to national polls
PM Narendra Modi achieves a historic win for BJP in the Delhi assembly elections, breaking a 26-year gap. His campaign, centered on development and localised […]
All-time record! Carey surpasses Gilchrist with 156-run knock
Australian cricketer Alex Carey became the first from his team to score 150 runs in Asian conditions, surpassing Adam Gilchrist’s previous record. Achieving this in […]